mRNA |
vorinostat:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
THZ-2-102-1 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.001 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
foretinib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
BRD-K48477130 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
CX-5461 |
GDSC1000 |
pan-cancer |
AAC |
0.099 |
0.002 |
mRNA |
OSI-930 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |